We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Michelle Lumasag has been assisting clients through the H1B Visa process since 2023.

As of 2022, Michelle Lumasag has succesfully submitted and recieved certification for 350 cases.

Michelle Lumasag is located in San Jose, CA, and has represented 5 employers for the H1B Visa Process

354
Cases Handled
350
Cases Certified
98.87%
Approval

Cases Handled by Michelle Lumasag

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-23159-093147 Certified Natural Sciences Managers Research And Development In Biotechnology Except Nanobiotechnology Gilead Sciences Inc 2023
I-200-23094-900463 Certified Natural Sciences Managers Research And Development In Biotechnology Except Nanobiotechnology Gilead Sciences Inc 2023
I-200-23061-816140 Certified Natural Sciences Managers Research And Development In Biotechnology Except Nanobiotechnology Gilead Sciences Inc 2023
I-200-23059-809156 Certified Natural Sciences Managers Research And Development In Biotechnology Except Nanobiotechnology Kite Pharma Inc 2023
I-200-23055-803255 Certified Natural Sciences Managers Research And Development In Biotechnology Except Nanobiotechnology Kite Pharma Inc 2023
I-200-23055-802495 Certified Natural Sciences Managers Research And Development In Biotechnology Except Nanobiotechnology Gilead Sciences Inc 2023
I-200-23040-761740 Certified Natural Sciences Managers Research And Development In Biotechnology Except Nanobiotechnology Gilead Sciences Inc 2023
I-200-22347-636015 Certified Natural Sciences Managers Research And Development In Biotechnology Except Nanobiotechnology Gilead Sciences Inc 2023
I-200-22339-620584 Certified Natural Sciences Managers Research And Development In Biotechnology Except Nanobiotechnology Gilead Sciences Inc 2023
I-200-23137-029821 Certified Medical And Health Services Managers Research And Development In Biotechnology Except Nanobiotechnology Gilead Sciences Inc 2023